Abreva News and Research

RSS
GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

BeaconEquity.com announces investment report featuring Avanir Pharmaceuticals

BeaconEquity.com announces investment report featuring Avanir Pharmaceuticals

Over-the-counter medications can help manage minor ailments

Over-the-counter medications can help manage minor ailments

GSK and NanoBio sign license agreement for nanoemulsion technology

GSK and NanoBio sign license agreement for nanoemulsion technology

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound